(NEW YORK POST) The Food and Drug Administration on Friday approved the emergency use of remdesivir, an experimental drug that is being tested in treating patients with coronavirus.
A federal trial that showed that treatment with the anti-viral drug could speed recovery in patients infected with COVID-19.
President Trump made the announcement from the White House with the drugmaker Gilead Sciences’ CEO Dan O’Day.
